Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-15T00:15:54.139Z.
Calculation as of: 2026-09-15T00:15:54.139Z.
Quote observation: 2026-09-14T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fff3b66753df9103aa6e8fa6e6867ea0bbba62446faea70668aaa7a177e0f800
PEG RATIO
N/A
HCA Healthcare, Inc.
Market Cap
$92.12B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| HCA Healthcare, Inc. (HCA) | $92.12B | N/A |
| Elevance Health Inc. (ELV)vs › | $92.00B | N/A |
| GSK plc (GSK)vs › | $100.28B | N/A |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.77B | N/A |
| Sanofi (SNY)vs › | $104.04B | N/A |
| McKesson Corporation (MCK)vs › | $106.65B | N/A |
| Cigna Corporation (CI)vs › | $76.64B | N/A |
| Stryker Corporation (SYK)vs › | $108.06B | N/A |
| Boston Scientific Corporation (BSX)vs › | $66.96B | N/A |
| Medtronic plc (MDT)vs › | $120.07B | N/A |
PEG Ratio
N/A
P/E Ratio
14.2
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute